Medicare Advantage has crossed a significant threshold in 2026: for the first time, a clear majority of all Medicare-eligible Americans are enrolled in a private Medicare Advantage plan rather than traditional fee-for-service Medicare. According to data tracked by KFF, total Medicare Advantage enrollment now exceeds 35 million people, representing roughly 54 percent of the Medicare population. That shift has enormous implications — not just for the insurance industry, but for the day-to-day experience of seniors trying to access doctors, manage prescriptions, and predict what their care will actually cost.
The growth of Medicare Advantage has not been uniform across the country. States like Florida, California, and Texas have some of the highest raw enrollment numbers simply because of their large senior populations, but penetration rates — meaning the share of Medicare beneficiaries in a given state who choose MA over Original Medicare — vary widely. In some counties in the South and Midwest, MA penetration exceeds 70 percent. In rural areas and parts of the Northeast, Original Medicare still dominates, partly because MA plan availability is thinner and provider networks can be more restrictive in lower-density regions. If you live in a rural county, it is worth checking Medicare.gov's Plan Finder tool each fall to see whether new plans have entered your area, because the landscape does shift year to year.
One of the most important stories for 2026 is what has happened to the extra benefits that drove so much MA enrollment growth in the first place. In 2023 and 2024, insurers were aggressively competing for members by loading plans with supplemental benefits: dental coverage worth hundreds of dollars, vision and hearing allowances, over-the-counter product cards loaded with $50 to $150 per quarter, gym memberships, and even meal delivery after hospitalizations. Many of those benefits have been scaled back or eliminated in 2026. Insurers cite rising medical costs, CMS payment adjustments, and tighter rules around what counts as a permissible supplemental benefit as reasons for the pullback. The practical result is that if you enrolled in a Medicare Advantage plan two or three years ago partly because of a generous dental or OTC benefit, you should not assume that benefit still exists at the same level — or at all — in your current plan.
This is not a minor administrative footnote. A beneficiary who was receiving a $500 annual dental allowance and a $200-per-quarter OTC card in 2024 could be looking at a plan that now offers $150 in dental coverage and no OTC card in 2026. That is a real reduction in value worth more than $1,000 annually. The Annual Enrollment Period — which runs October 15 through December 7 each year — is the window when you can switch MA plans, return to Original Medicare, or make other coverage changes that take effect January 1. If you did not actively compare plans during the 2025 AEP for your 2026 coverage, you may be in a plan that no longer matches what you need. The Open Enrollment Period, running January 1 through March 31, allows one additional switch from one MA plan to another, or a return to Original Medicare, so there is still a window available mid-year if your 2026 plan is not working for you.
On the cost-sharing side, 2026 brings a notable change that applies to all Medicare Part D drug coverage, including the drug benefits embedded in most Medicare Advantage plans. The Inflation Reduction Act's $2,000 annual out-of-pocket cap on Part D drug costs took effect in 2025 and remains in place for 2026. This is genuinely significant for beneficiaries who take expensive specialty medications. Before this cap existed, some seniors were spending $5,000, $8,000, or more per year on drugs after hitting the old catastrophic coverage threshold. The $2,000 cap means that once you have paid that amount in covered drug costs in a calendar year, your plan covers 100 percent of additional drug costs for the rest of the year. If you are on high-cost medications for conditions like cancer, rheumatoid arthritis, or multiple sclerosis, this cap may be one of the most valuable protections in your current coverage.
CMS has also been tightening its oversight of Medicare Advantage plans in ways that are reshaping the market. The agency has adjusted its risk adjustment payment methodology — the formula that determines how much the federal government pays insurers for each enrollee based on their health status. CMS found that some insurers had been overcoding diagnoses to make their patient populations appear sicker than they were, which inflated payments. The corrections to this system have reduced revenue for some large MA insurers, and that financial pressure is part of why you are seeing benefit reductions and, in some cases, plan exits from certain markets. Several major insurers announced reductions in their MA footprints for 2026, meaning some plans that existed in your county in 2025 may no longer be available. If your plan was discontinued, you should have received a notice and been automatically enrolled in a comparable plan, but you have the right to switch during a Special Enrollment Period triggered by that plan termination.
Star ratings are another factor worth understanding as you evaluate your Medicare Advantage plan. CMS rates MA plans on a scale of one to five stars based on quality measures including how well plans manage chronic conditions, member satisfaction, and how quickly they process appeals. Plans that earn four or five stars receive bonus payments from CMS, which typically allows them to offer richer benefits. In 2026, the distribution of star ratings has shifted, with fewer plans earning five stars compared to prior years after CMS tightened its measurement methodology. You can look up your plan's star rating at Medicare.gov. A plan with three stars or below may be worth reconsidering, particularly if you have complex health needs, because lower-rated plans have historically had more issues with prior authorization denials and care coordination.
Prior authorization remains one of the most contentious issues in Medicare Advantage. Unlike Original Medicare, which generally pays for any covered service a doctor orders, MA plans require advance approval for many procedures, specialist visits, and post-acute care like skilled nursing or home health. CMS finalized rules in recent years requiring MA plans to make prior authorization decisions faster — 72 hours for urgent requests and seven calendar days for standard requests — and to provide clearer reasons when they deny care. However, beneficiary advocates and physician groups continue to report that prior authorization denials remain a significant barrier to timely care. If your MA plan denies a service your doctor has ordered, you have the right to appeal. The first level of appeal goes to the plan itself and must be decided within 60 days for standard appeals or 72 hours for expedited appeals. If the plan upholds the denial, you can escalate to an independent review organization. Do not simply accept a denial as final.
For beneficiaries who are considering switching from Medicare Advantage back to Original Medicare, there is an important coverage gap to understand. Original Medicare does not cap your out-of-pocket costs the way MA plans do, and most people who return to Original Medicare want to add a Medigap supplemental policy to cover cost-sharing. However, outside of specific guaranteed issue windows — such as when you first enroll in Medicare at 65, or when an MA plan leaves your area — insurers in most states can use medical underwriting to deny you Medigap coverage or charge higher premiums based on your health history. If you are in one of the birthday rule states, including California, Oregon, Nevada, Illinois, or several others, you have a 30-day window each year around your birthday to switch Medigap plans without medical underwriting. That is a meaningful protection if you want to change your supplemental coverage without risking denial based on a pre-existing condition.
Looking at the broader enrollment trends, the growth of Medicare Advantage has slowed somewhat compared to the rapid expansion years of 2020 through 2023. Analysts attribute this partly to the benefit pullbacks described above — the value proposition of MA over Original Medicare is less obvious when the extra benefits shrink — and partly to increased awareness among beneficiaries about prior authorization and network restrictions. Some seniors who switched to MA plans for the dental and vision perks are now switching back to Original Medicare after experiencing coverage denials or finding that their preferred specialists are not in-network. This is not to say MA is the wrong choice for everyone — for many beneficiaries, particularly those who are relatively healthy and want the simplicity of a single plan covering medical and drug costs with a predictable premium, MA can still be a strong option. The key is making an active, informed choice rather than staying in a plan by default.
If you want personalized help comparing your options, the State Health Insurance Assistance Program — known as SHIP — provides free, unbiased counseling in every state. SHIP counselors are not insurance agents and do not earn commissions, so their guidance is genuinely in your interest. You can find your local SHIP program by calling 1-800-MEDICARE or visiting shiphelp.org. Given how much the Medicare Advantage landscape has shifted in 2026, taking an hour to review your current plan with a SHIP counselor before the next Annual Enrollment Period in October could be one of the most valuable health-related decisions you make this year.